Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
72 hedge funds and large institutions have $239M invested in Apollo Endosurgery, Inc. in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 29 increasing their positions, 9 reducing their positions, and 9 closing their positions.
4,586% more call options, than puts
Call options by funds: $984K | Put options by funds: $21K
222% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 9
200% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 9
50% more capital invested
Capital invested by funds: $159M → $239M (+$79.9M)
31% more funds holding
Funds holding: 55 → 72 (+17)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$20M |
| 2 |
DM
Deerfield Management
New York
|
+$15.3M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$10.9M |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$6.46M |
| 5 |
CI
CPMG Inc
Dallas,
Texas
|
+$5.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$2.67M |
| 2 |
Renaissance Technologies
New York
|
-$1.09M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$613K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$387K |
| 5 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$358K |
APEN Hedge Fund Activity: Q4 2021 in Review
72 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q4 2021, worth a combined $239M — up 50% from $159M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new APEN positions and 9 closed out — a net gain of 18 holders — while 29 added to existing stakes and 9 trimmed.
The largest buyer was Soleus Capital Management, opening a new position worth an estimated $20M. The largest seller was Invesco, exiting entirely with an estimated $2.67M sold.
- 72 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q4 2021, up from 55 in Q3 2021.
- Funds reported $239M of Apollo Endosurgery, Inc. stock for Q4 2021, up 50% quarter-over-quarter.
- 27 funds opened new Apollo Endosurgery, Inc. positions in Q4 2021 and 9 closed out, a net change of +18 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q4 2021 was Soleus Capital Management, an estimated $20M added.
- The largest Apollo Endosurgery, Inc. seller in Q4 2021 was Invesco, an estimated $2.67M sold.
Based on aggregated 13F filings for Q4 2021.